Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Insomnia Treatment Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Drugs(Somatostatin Analogs, Growth Hormone Receptor Antagonists, Dopamine Agonists, Combination Therapy)
4.2.2. By Route of administration (Oral, Subcutaneous ,Others)
4.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
4.2.4. By Region
4.2.5. By Company (2022)
4.3. Market Map
4.3.1. By Drugs
4.3.2. By Route of administration
4.3.3. By Distribution Channel
4.3.4. By Region
5. Asia Pacific Insomnia Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drugs
5.2.2. By Route of administration
5.2.3. By Distribution Channel
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Insomnia Treatment Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Drugs
5.3.1.2.2. By Route of administration
5.3.1.2.3. By Distribution Channel
5.3.2. India Insomnia Treatment Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Drugs
5.3.2.2.2. By Route of administration
5.3.2.2.3. By Distribution Channel
5.3.3. Australia Insomnia Treatment Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Drugs
5.3.3.2.2. By Route of administration
5.3.3.2.3. By Distribution Channel
5.3.4. Japan Insomnia Treatment Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Drugs
5.3.4.2.2. By Route of administration
5.3.4.2.3. By Distribution Channel
5.3.5. South Korea Insomnia Treatment Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Drugs
5.3.5.2.2. By Route of administration
5.3.5.2.3. By Distribution Channel
6. Europe Insomnia Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drugs
6.2.2. By Route of administration
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Insomnia Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drugs
6.3.1.2.2. By Route of administration
6.3.1.2.3. By Distribution Channel
6.3.2. Germany Insomnia Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drugs
6.3.2.2.2. By Route of administration
6.3.2.2.3. By Distribution Channel
6.3.3. Spain Insomnia Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drugs
6.3.3.2.2. By Route of administration
6.3.3.2.3. By Distribution Channel
6.3.4. Italy Insomnia Treatment Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Drugs
6.3.4.2.2. By Route of administration
6.3.4.2.3. By Distribution Channel
6.3.5. United Kingdom Insomnia Treatment Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Drugs
6.3.5.2.2. By Route of administration
6.3.5.2.3. By Distribution Channel
7. North America Insomnia Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drugs
7.2.2. By Route of administration
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Insomnia Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drugs
7.3.1.2.2. By Route of administration
7.3.1.2.3. By Distribution Channel
7.3.2. Mexico Insomnia Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drugs
7.3.2.2.2. By Route of administration
7.3.2.2.3. By Distribution Channel
7.3.3. Canada Insomnia Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drugs
7.3.3.2.2. By Route of administration
7.3.3.2.3. By Distribution Channel
8. South America Insomnia Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drugs
8.2.2. By Route of administration
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Insomnia Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drugs
8.3.1.2.2. By Route of administration
8.3.1.2.3. By Distribution Channel
8.3.2. Argentina Insomnia Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drugs
8.3.2.2.2. By Route of administration
8.3.2.2.3. By Distribution Channel
8.3.3. Colombia Insomnia Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drugs
8.3.3.2.2. By Route of administration
8.3.3.2.3. By Distribution Channel
9. Middle East and Africa Insomnia Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drugs
9.2.2. By Route of administration
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Insomnia Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drugs
9.3.1.2.2. By Route of administration
9.3.1.2.3. By Distribution Channel
9.3.2. Saudi Arabia Insomnia Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drugs
9.3.2.2.2. By Route of administration
9.3.2.2.3. By Distribution Channel
9.3.3. UAE Insomnia Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drugs
9.3.3.2.2. By Route of administration
9.3.3.2.3. By Distribution Channel
9.3.4. Egypt Insomnia Treatment Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Drugs
9.3.4.2.2. By Route of administration
9.3.4.2.3. By Distribution Channel
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Global Insomnia Treatment Market: SWOT Analysis
13. Porter?s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. Competitive Landscape
14.1. Recordati Rare Diseases
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Current Capacity Analysis
14.1.5. Financials (In case of listed)
14.1.6. Recent Developments
14.1.7. SWOT Analysis
14.2. Pfizer Inc.
14.3. Validus Pharmaceuticals LLC
14.4. Ipsen Pharma
14.5. Crinetics Pharmaceuticals, Inc.
14.6. Amryt Pharma plc
14.7. Debiopharm
14.8. ADVANZ PHARMA
14.9. Novartis Pharmaceuticals Corporation
14.10. Amolyt Pharma
15. Strategic Recommendations
16. About Us & Disclaimer